Status:
COMPLETED
Role of Proteomics and Metallomics in Cerebral Vasospasm Following Subarachnoid Hemorrhage
Lead Sponsor:
State University of New York - Upstate Medical University
Conditions:
Subarachnoid Hemorrhage
Cerebral Vasospasm
Eligibility:
All Genders
18-89 years
Brief Summary
The purpose of this study is to determine the role of Proteomics and Metallomics in Cerebral Vasospasm following Subarachnoid Hemorrhage
Eligibility Criteria
Inclusion
- Non traumatic SAH documented by CT scan
- Patient with SAH who would need external ventricular drain (EVD) for the management of hydrocephalus
- Patients with normal pressure Hydrocephalus that require an external drain
- Control (non - hemorrhagic) group - CSF collected from patients with posterior fossa tumor or stroke with EVD in place for the management of hydrocephalus.
Exclusion
- Recent infection within last 1 month of presentation- can increase inflammatory markers
- Recent surgery or acute myocardial infarction within last 1 month of presentation
- Age \> 89 years or \< 18 years
Key Trial Info
Start Date :
April 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2013
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT01799018
Start Date
April 1 2011
End Date
June 1 2013
Last Update
November 20 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
State University of New York Upstate Medical University
Syracuse, New York, United States, 13210